Status:
UNKNOWN
Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia
Lead Sponsor:
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Conditions:
Mild Cognitive Impairment
Dementia
Eligibility:
All Genders
55+ years
Brief Summary
Coronavirus disease 2019 has forced worldwide the implementation of unprecedented restrictions to control its rapid spread and mitigate its impact. The Spanish government has enforced social distancin...
Detailed Description
Coronavirus disease 2019 (COVID-19) has forced worldwide government authorities to implement unprecedented restrictions to control its rapid spread and mitigate its impact. In response to the outbreak...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Having participated in the SMART 4 MD, TV-AssistDem and INFINITy clinical trials
Exclusion
Key Trial Info
Start Date :
May 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04385797
Start Date
May 4 2020
End Date
December 31 2020
Last Update
December 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto de Investigacion Biomedica de Malaga-IBIMA
Málaga, Spain, 29009